McFadden David D

Show results for

Unknown (13)
Transcriptomics (1)
Metabolomics (1)

Organisms

Mus musculus (1)

Repository

biostudies-arrayexpress (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

GCMS-QP2010 Plus (Shimadzu) (1)

Publication Date

2014 (1)
2018 (1)

CHEBI ID

CHEBI:10642 (1)
CHEBI:12936 (1)
CHEBI:138264 (1)
CHEBI:14314 (1)
CHEBI:15428 (1)
CHEBI:15603 (1)
CHEBI:16015 (1)
CHEBI:16199 (1)
CHEBI:16235 (1)
CHEBI:16335 (1)
CHEBI:16643 (1)
CHEBI:16704 (1)
CHEBI:16708 (1)
CHEBI:16857 (1)
CHEBI:16865 (1)
CHEBI:16919 (1)
CHEBI:16958 (1)
CHEBI:16977 (1)
CHEBI:16988 (1)
CHEBI:17057 (1)
CHEBI:17148 (1)
CHEBI:17191 (1)
CHEBI:17203 (1)
CHEBI:17268 (1)
CHEBI:17295 (1)
CHEBI:17317 (1)
CHEBI:17368 (1)
CHEBI:17568 (1)
CHEBI:17634 (1)
CHEBI:17821 (1)

Metabolite Name

5-Hydroxyindole-3-acetic acid, 3 TMS, 35.49, 2212 (1)
Adenine, 2 TMS, 29.74, 1869 (1)
Adenosine, 4 TMS, 41.49, 2642 (1)
Adenosine, x TMS, 40.95, 2603 (1)
Ascorbic acid, x TMS, 29.19, 1844 (1)
Aspartic acid, 2 TMS, 20.54, 1428 (1)
Benzoic acid, 1 TMS, 16.26, 1254 (1)
Cellobiose, x TMS, 42.19, 2962 (1)
Citric acid, 4 TMS, 28.69, 1817 (1)
Creatine. x TMS, 23.39, 1551 (1)
D-(+)-Galactose, 5 TMS, MEOX, 29.94, 1880 (1)
D-(+)-Galactose, 5 TMS, MEOX, 29.94, 1880 (alt. m/z quant. high dynamic range) (1)
D-(+)-Galactose, 5 TMS, MEOX, 29.94, 1880 (alt. m/z quant.) (1)
D-(+)-Glucose, 5 TMS, MEOX, 30.38, 1902 (alt. m/z quant. high dynamic range) (1)
D-(+)-Sorbose, 5 TMS, MEOX, 29.67, 1866 (1)
D-(+)-Turanose, 7 TMS, 42.29, 2702 (1)
D-(-)-Ribose, 4 TMS, MEOX, 25.89, 1678 (1)
D-Fructose-1-phosphate, x TMS, 36.58, 2290 (1)
D-Fructose-6-phosphate 6TMS, MEOX, 36.72, 2300 (1)
D-Glucose-6-phosphate, 6 TMS, MEOX, 36.95, 2312 (1)
D-Glucose-6-phosphate, 6 TMS, MEOX, 37.23, 2332 (1)
D-Sorbitol, 6 TMS, 30.60, 1915 (1)
D-sorbitol 13C6 m/z_322 (alt. m/z quant.) (1)
D-sorbitol 13C6 m/z_323 (reference standard) (1)
D-sorbitol-1-13C m/z_205 (alt. m/z quant.) (1)
D-sorbitol-1-13C m/z_206 (alt. m/z quant.) (1)
D-sorbitol-1-13C m/z_319 (alt. m/z quant.) (1)
D-sorbitol-1-13C m/z_320 (alt. m/z quant.) (1)
DL-Ornithine, 3 TMS, 24.71, 1623 (1)
DL-Ornithine, 4 TMS, 28.65, 1815 (1)

Study type

Transcription profiling by array (1)

Release Date

2021 (5)
2022 (3)
2023 (2)
2014 (1)
2025 (1)
2024 (1)
2020 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Survival, gene and metabolite responses of Litoria verreauxii alpina frogs to fungal disease chytridiomycosis

The fungal skin disease chytridiomycosis has caused the devastating decline and extinction of hundreds of amphibian species globally, yet the potential for evolving resistance, and the underlying pathophysiological mechanisms remain poorly understood. We exposed 406 naïve, captive-raised alpine tree...

2018-01-09 | MTBLS457 | MetaboLights

p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.

Anaplastic thyroid carcinoma (ATC) has among the worst prognosis of any solid malignancy. The low incidence of the disease has in part precluded systematic clinical trials and tissue collection, and there has been little progress in developing effective therapies. BRAF and TP53 mutations co-occur ...

ORGANISM(S): Mus musculus

2014-04-02 | E-GEOD-55933 | biostudies-arrayexpress

Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.

Not available

S-EPMC9126186 | biostudies-literature

Dexamethasone in Hospitalized Patients with Covid-19.

Not available

S-EPMC7383595 | biostudies-literature

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.

Not available

S-EPMC7556338 | biostudies-literature

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.